Overview
Naoto Mori practices in Chiba, Japan. Mr. Mori is rated as an Experienced expert by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Xanthoma, Familial Hypercholesterolemia, Coronary Heart Disease, Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and Percutaneous Coronary Intervention (PCI).
His clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Defective Apolipoprotein B-100.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- XanthomaMr. Mori isAdvanced. Learn about Xanthoma.
- Experienced
- Acute Coronary SyndromeMr. Mori isExperienced. Learn about Acute Coronary Syndrome.
- AnginaMr. Mori isExperienced. Learn about Angina.
- Aortic Valve StenosisMr. Mori isExperienced. Learn about Aortic Valve Stenosis.
- Coronary Heart DiseaseMr. Mori isExperienced. Learn about Coronary Heart Disease.
- Defective Apolipoprotein B-100Mr. Mori isExperienced. Learn about Defective Apolipoprotein B-100.
- Familial HypercholesterolemiaMr. Mori isExperienced. Learn about Familial Hypercholesterolemia.